You just read:

Athenex Announces the US FDA Allowance of the Investigational New Drug Application of Oratopo, A Combination of HM30181A and Oral Topotecan For the Treatment of Advanced Cancer

News provided by

Athenex, Inc.

28 Mar, 2017, 16:40 ET